Stadler Nicola, Fingernagel Thomas, Hofstaetter Stefan G, Trieb Klemens
Department of Orthopaedics, Klinikum Wels-Grieskirchen , Wels, Austria.
Clin Pract. 2015 Feb 10;5(1):697. doi: 10.4081/cp.2015.697. eCollection 2015 Jan 28.
Although the giant cell tumor of bone is generally classified as a benign tumor it can rarely metastasize and has a potential risk of local recurrence. We want to report about a female patient who suffered from a recurrence of a giant cell tumor of bone after the implantation of a total endoprosthesis of the knee joint. We have treated her with denosumab, which is a receptor activator of nuclear factor kappa-B ligand inhibitor. In this case report we want to present a new option to treat this kind of neoplasm.
尽管骨巨细胞瘤通常被归类为良性肿瘤，但它很少会发生转移，并且存在局部复发的潜在风险。我们想要报告一位女性患者，她在膝关节全关节置换术后出现了骨巨细胞瘤复发。我们用狄诺塞麦对她进行了治疗，狄诺塞麦是一种核因子κB受体活化因子配体抑制剂。在本病例报告中，我们想介绍一种治疗这类肿瘤的新方法。
